Are Antipyretic Medications Compatible with SARS-CoV-2 Vaccines?
The University of Louisville Journal of Respiratory Infections · 20.04.2022 · 6 (1)
DOI: 10.55504/2473-2869.1242 ↗Kurz gefasst
Fachartikel in der Zeitschrift The University of Louisville Journal of Respiratory Infections, online erschienen am 20.04.2022. Verfasst von Sharanya S E Santhi und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Vaccine hesitancy is an issue that should be addressed to maximize protection from serious COVID-19.SARS-CoV-2 vaccination hesitancy in the United States ranges from 21 to 42%.[1] Fear of adverse effects and concerns about safety are some of the main reasons for refusing to be immunized.[2,3] Vaccinations can induce adverse reactions, such as injection site tenderness, headache, myalgia, and arthralgia.Fever is occasionally a systemic side effect.[4]People often self-treat these problems with antipyretic and/or analgesic drugs; physicians sometimes recommend these as well.
Zitieren
APA
Santhi, S. S. E., Rayamajhi, N., & Lippmann, S. B. (2022). Are Antipyretic Medications Compatible with SARS-CoV-2 Vaccines?. The University of Louisville Journal of Respiratory Infections, 6(1). https://doi.org/10.55504/2473-2869.1242
Vancouver
Santhi SSE, Rayamajhi N, Lippmann SB. Are Antipyretic Medications Compatible with SARS-CoV-2 Vaccines?. The University of Louisville Journal of Respiratory Infections. 2022;6(1). doi:10.55504/2473-2869.1242
BibTeX
@article{Santhi2022,
author = {Santhi, Sharanya S E and Rayamajhi, Niguma and Lippmann, Steven B},
title = {Are Antipyretic Medications Compatible with SARS-CoV-2 Vaccines?},
journal = {The University of Louisville Journal of Respiratory Infections},
year = {2022},
volume = {6},
number = {1},
doi = {10.55504/2473-2869.1242}
}
EUVIMED